{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:11:21Z","timestamp":1771920681634,"version":"3.50.1"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19) is an epidemic respiratory disease caused due to the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In China, the National Health Commission of China announced that patients with COVID-19 who were treated with traditional Chinese medicines (TCMs) combined with antiviral drugs effectively alleviated their symptoms and recovered. Among these TCMs, Xuebijing (XBJ) injection plays an important role in the treatment of patients with COVID-19. However, this was a puzzle that what will be the clinical efficacy and safety of XBJ injection for COVID-19 treatment, and what are the potential mechanisms behind XBJ injection?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To search for articles on \u201cXuebijing injection in the treatment of COVID-19\u201d in PubMed, use the following query: (Xuebijing injection OR Xuebijing) AND (COVID-19 OR SARS-CoV-2 OR severe pneumonia). We added filters for \u201cClinical Trial,\u201d \u201cRandomized Controlled Trial,\u201d or \u201cReview\u201d to focus on specific study types, and limit the search to recent years (2010\u20132025) and English-language articles for more targeted results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>XBJ injection in combination with regular therapy has been shown to improve overall efficacy, reduce 28-day mortality, improve lung CT recovery and reduce pro-inflammatory markers in patients with COVID-19. The high affinity for angiotensin converting enzyme 2, inhibition of neutrophil extracellular trap release and prevention of cell death and inflammation may be the main molecular mechanisms of XBJ injection in the treatment of COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review synthesizes the current evidence on the clinical efficacy and safety of XBJ injection in the treatment of COVID-19. Our analysis indicates that XBJ injection, when used in combination with standard therapy, significantly improves overall efficacy, reduces 28-day mortality, enhances lung CT recovery, and decreases pro-inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6). These findings suggest that Xuebijing injection is a promising adjunctive treatment for COVID-19, particularly in severe cases, although it must be confirmed through rigorous pharmacological and clinical studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1667022","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:40:03Z","timestamp":1768372803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Xuebijing injection in the treatment of COVID-19: An update on clinical studies, potentially active metabolites and mechanisms"],"prefix":"10.3389","volume":"16","author":[{"given":"Ziyan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Emergency, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[{"name":"Hong Kong Baptist University","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Internal, Kelan County Traditional Chinese Medicine Hospital","place":["Xinzhou, Shanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1549419","DOI":"10.3389\/fphar.2025.1549419","article-title":"Efficacy of xuebijing injection on pulmonary ventilation improvement in acute pancreatitis: a systematic review and meta-analysis","volume":"16","author":"Bin","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1080\/00032711003698739","article-title":"Development and validation of a HPLC method for the determination of five bioactive compounds in the \u201cXuebijing\u201d injection","volume":"43","author":"Chen","year":"2010","journal-title":"Anal. Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.16155\/j.0254-1793.2012.05.004","article-title":"In vivo pharmacokinetic study of Xuebijing injection in rats","volume":"32","author":"Chen","year":"2012","journal-title":"Yao Wu Fen Xi Za Zhi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3969\/j.issn.1671-945X.2020.10.057","article-title":"Efficacy of Xuebijing injection in the treatment of COVID-19 and its effect on CRP","volume":"18","author":"Chen","year":"2020","journal-title":"Zhong Guo Chu Fang. Yao"},{"key":"B6","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.arr.2023.102138","article-title":"Universal masking during COVID-19 outbreaks in aged care settings: a systematic review and meta-analysis","volume":"93","author":"Chen","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"156629","DOI":"10.1016\/j.phymed.2025.156629","article-title":"Therapeutic efficacy of Xuebijing injection in treating severe acute pancreatitis and its mechanisms of action: a comprehensive survey","volume":"140","author":"Chen","year":"2025","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.3390\/ijms222011078","article-title":"Research progress in Chinese herbal medicines for treatment of sepsis: pharmacological action, phytochemistry, and pharmacokinetics","volume":"22","author":"Cheng","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/aps.2015.103","article-title":"Pharmacokinetics and disposition of monoterpene glycosides derived from Paeonia lactiflora roots (Chishao) after intravenous dosing of antiseptic XueBiJing injection in human subjects and rats","volume":"37","author":"Cheng","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"B10","unstructured":"Guidelines for the diagnosis and treatment of COVID-19\n          \n          \n          2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/e24040439","article-title":"Fast phylogeny of SARS-CoV-2 by compression","volume":"24","author":"Cilibrasi","year":"2022","journal-title":"Entropy (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/ijms17122120","article-title":"Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns","volume":"17","author":"Cilloniz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"156573","DOI":"10.1016\/j.phymed.2025.156573","article-title":"Herbal-based Xuebijing injection ameliorated vascular endothelial dysfunction via inhibiting ACLY\/MYB\/RIG-I axis in sepsis-associated lung injury","volume":"140","author":"Cui","year":"2025","journal-title":"Phytomedicine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/v17050619","article-title":"SARS-CoV-2 spike protein and long COVID-Part 2: understanding the impact of spike protein and cellular receptor interactions on the pathophysiology of long COVID syndrome","volume":"17","author":"de Melo","year":"","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/v17050617","article-title":"SARS-CoV-2 spike protein and long COVID-Part 1: impact of spike protein in pathophysiological mechanisms of long COVID syndrome","volume":"17","author":"de Melo","year":"","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.crtox.2023.100123","article-title":"Neuroprotective potentials of ferulic acid against intracerebral hemorrhage COVID-19 through using network pharmacology approach and molecular docking analysis","volume":"5","author":"Dong","year":"2023","journal-title":"Curr. Res. Toxicol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","article-title":"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines","volume":"54","author":"Fernandes","year":"2022","journal-title":"Ann. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.21037\/apm-20-1478","article-title":"Xuebijing injection in the treatment of COVID-19: a retrospective case-control study","volume":"9","author":"Guo","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2313","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: a review","volume":"32","author":"Hadj","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105224","DOI":"10.1016\/j.phrs.2020.105224","article-title":"Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms","volume":"163","author":"He","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1012866","DOI":"10.1371\/journal.pcbi.1012866","article-title":"Uncovering temperature sensitivity of West Nile virus transmission: novel computational approaches to mosquito-pathogen trait responses","volume":"21","author":"Heidecke","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2015.02.015","article-title":"Senkyunolide I protects rat brain against focal cerebral ischemia-reperfusion injury by up-regulating p-Erk1\/2, Nrf2\/HO-1 and inhibiting caspase 3","volume":"1605","author":"Hu","year":"2015","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.brainres.2016.08.012","article-title":"Senkyunolide I attenuates oxygen-glucose deprivation\/reoxygenation-induced inflammation in microglial cells","volume":"1649","author":"Hu","year":"2016","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"119729","DOI":"10.1016\/j.jep.2025.119729","article-title":"Integrated metabolomics and network pharmacology reveal the mechanisms of Xuebijing in counteracting sepsis-induced myocardial dysfunction","volume":"347","author":"Hu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/pca.1284","article-title":"Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS","volume":"22","author":"Huang","year":"2011","journal-title":"Phytochem. Anal."},{"key":"B26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1134\/S1061934813040023","article-title":"Simultaneous determination of thirteen main components and identification of eight major metabolites in Xuebijing Injection by UPLC\/Q-TOF","volume":"68","author":"Huang","year":"2013","journal-title":"J. Anal. Chem."},{"key":"B27","first-page":"2395","article-title":"Simultaneous HPLC determination of 11 essential compounds in Xuebijing injection","volume":"35","author":"Ji","year":"2010","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13054-025-05441-4","article-title":"Traditional Chinese medicine for sepsis: advancing from evidence to innovative drug discovery","volume":"29","author":"Ji","year":"2025","journal-title":"Crit. Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10805","DOI":"10.1007\/s13277-016-4970-9","article-title":"Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology","volume":"37","author":"Khan","year":"","journal-title":"Tumour Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0148530","DOI":"10.1371\/journal.pone.0148530","article-title":"Systems biology approaches for the prediction of possible role of Chlamydia pneumoniae proteins in the etiology of lung cancer","volume":"11","author":"Khan","year":"","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30830","DOI":"10.18632\/oncotarget.8306","article-title":"Prediction of mycoplasma hominis proteins targeting in mitochondria and cytoplasm of host cells and their implication in prostate cancer etiology","volume":"8","author":"Khan","year":"2017","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10614","DOI":"10.3390\/molecules170910614","article-title":"Advances in the chemical analysis and biological activities of chuanxiong","volume":"17","author":"Li","year":"2012","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.dmpk.2015.10.005","article-title":"Pharmacokinetics of catechols in human subjects intravenously receiving XueBiJing injection, an emerging antiseptic herbal medicine","volume":"31","author":"Li","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.13313\/j.issn.1673-4890.20180316003","article-title":"Determination of the active ingredients in Xuebijing injection by HPLC method","volume":"20","author":"Li","year":"2018","journal-title":"Zhong Guo Xian Dai Zhong Yao"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.apsb.2019.06.003","article-title":"High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113301","DOI":"10.1016\/j.jep.2020.113301","article-title":"The current evidence for the treatment of sepsis with Xuebijing injection: bioactive constituents, findings of clinical studies and potential mechanisms","volume":"265","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.16808\/j.cnki.issn1003-7705.2022.01.003","article-title":"Clinical study on the treatment of 24 suspected cases of COVID-19 with Xuebijing injection","volume":"38","author":"Li","year":"2022","journal-title":"Hunan Zhong Yi Za Zhi"},{"key":"B38","doi-asserted-by":"publisher","first-page":"341799","DOI":"10.1016\/j.aca.2023.341799","article-title":"An aggregation-induced emission sensor combined with UHPLC-Q-TOF\/MS for fast identification of anticoagulant active ingredients from traditional Chinese medicine","volume":"1279","author":"Li","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.2147\/jir.S507468","article-title":"Exploring the mechanism of action of xuebijing injection in treating acute respiratory distress syndrome based on network pharmacology and animal experiments","volume":"18","author":"Li","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.joim.2025.04.002","article-title":"Xuebijing injection reduces COVID-19 patients' mortality as influenced by the neutrophil to lymphocyte platelet ratio","volume":"23","author":"Liao","year":"2025","journal-title":"J. Integr. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/antiox14030248","article-title":"Identifying baicalein as a key bioactive compound in XueBiJing targeting KEAP1: implications for antioxidant effects","volume":"14","author":"Lin","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/vaccines13050481","article-title":"Challenges and innovations in pharmacovigilance and signal management during the COVID-19 pandemic: an industry perspective","volume":"13","author":"Lino","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.chmed.2020.04.003","article-title":"Traditional Chinese medicine contributes to the treatment of COVID-19 patients","volume":"12","author":"Liu","year":"2020","journal-title":"Chin. Herb. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.intimp.2014.10.018","article-title":"Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways","volume":"23","author":"Liu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3760\/cma.j.cn121430-20210514-00714","article-title":"A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019","volume":"33","author":"Liu","year":"2021","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e70494","DOI":"10.1111\/tpj.70494","article-title":"DNA methylation controls the expression of tanshinone synthesis genes and the tanshinone accumulation in Salvia miltiorrhiza and Salvia bowleyana","volume":"123","author":"Liu","year":"2025","journal-title":"Plant J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.eclinm.2025.103341","article-title":"Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial","volume":"86","author":"Lou","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.eujim.2021.101305","article-title":"The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: a prospective randomized controlled trial","volume":"42","author":"Luo","year":"2021","journal-title":"Eur. J. Integr. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.13412\/j.cnki.zyyl.2022.05.011","article-title":"Meta-Analysis of efficacy and safety of xuebijing in the treatment of coronavirus disease 2019","volume":"38","author":"Luo","year":"2022","journal-title":"Zhong Yao Yao Li Yu Lin. Chuang"},{"key":"B50","doi-asserted-by":"publisher","first-page":"105073","DOI":"10.1016\/j.phrs.2020.105073","article-title":"The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2","volume":"160","author":"Ma","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/biom13111565","article-title":"An overview of SARS-CoV-2 etiopathogenesis and recent developments in COVID-19 vaccines","volume":"13","author":"Mathew","year":"2023","journal-title":"Biomolecules"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20202583","article-title":"Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6","volume":"41","author":"Niu","year":"2021","journal-title":"Biosci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.19540\/j.cnki.cjcmm.20180611.010","article-title":"Simultaneous determination of nine constituents of Xuebijing Injection in rat plasma and their pharmacokinetics by LC-MS\/MS","volume":"43","author":"Ouyang","year":"2018","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B54","doi-asserted-by":"publisher","first-page":"971687","DOI":"10.3389\/fendo.2022.971687","article-title":"Preclinical findings: the pharmacological targets and molecular mechanisms of ferulic acid treatment for COVID-19 and osteosarcoma via targeting autophagy","volume":"13","author":"Pang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ccm.2022.11.008","article-title":"Antiviral treatment of Coronavirus Disease-2019 Pneumonia","volume":"44","author":"Radcliffe","year":"2023","journal-title":"Clin. Chest Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/fvl-2020-0079","article-title":"Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-CoV-2 inhibitors","volume":"15","author":"Salman","year":"2020","journal-title":"Future Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"115410","DOI":"10.1016\/j.ab.2023.115410","article-title":"Overview of the different methods for RNA preparation in COVID-19 diagnosis process during the pandemic","volume":"686","author":"Shahi","year":"2023","journal-title":"Anal. Biochem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1054176","DOI":"10.3389\/fphar.2022.1054176","article-title":"Xuebijing injection inhibited neutrophil extracellular traps to reverse lung injury in sepsis mice via reducing Gasdermin D","volume":"13","author":"Shang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/v13020202","article-title":"COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention","volume":"13","author":"Sharma","year":"2021","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1186\/s12889-022-13720-w","article-title":"Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India","volume":"22","author":"Sharma","year":"2022","journal-title":"BMC Public Health"},{"key":"B61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/00498254.2019.1668983","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of hydroxysafflor yellow A in patients with traumatic brain injury after intravenous administration of Xuebijing using LC-MS\/MS method","volume":"50","author":"Sheng","year":"2020","journal-title":"Xenobiotica"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6338486","DOI":"10.1155\/japr\/6338486","article-title":"PubChem BioAssays 1063: a poorly exploited source of new antileishmanial compounds","volume":"2025","author":"Sifontes-Rodr\u00edguez","year":"2025","journal-title":"J. Parasitol. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"933824","DOI":"10.3389\/fcimb.2022.933824","article-title":"Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy","volume":"12","author":"Singh","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1097\/ccm.0000000000003842","article-title":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial","volume":"47","author":"Song","year":"2019","journal-title":"Crit. Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"106080","DOI":"10.1016\/j.ijantimicag.2020.106080","article-title":"COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)","volume":"56","author":"Song","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B66","doi-asserted-by":"publisher","first-page":"755536","DOI":"10.3389\/fphar.2022.755536","article-title":"Weaker response to XueBiJing treatment in severe community-acquired pneumonia patients with higher body mass index or hyperglycemia: a post hoc analysis of a randomized controlled trial","volume":"13","author":"Song","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"12889","DOI":"10.3390\/ijms222312889","article-title":"Recent advances in biological activity, new formulations and prodrugs of ferulic acid","volume":"22","author":"Stompor-Gor\u0105cy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/ptr.3166","article-title":"The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice","volume":"24","author":"Sun","year":"2010","journal-title":"Phytother. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"16921","DOI":"10.1038\/s41598-017-17170-y","article-title":"Chemical profiling and quantification of XueBiJing injection, a systematic quality control strategy using UHPLC-Q Exactive hybrid quadrupole-orbitrap high-resolution mass spectrometry","volume":"7","author":"Sun","year":"2017","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"631","DOI":"10.19852\/j.cnki.jtcm.20230517.002","article-title":"Effectiveness and safety of Xuebijing injection for patients with coronavirus disease 2019: a systematic review and metaanalysis","volume":"43","author":"Sun","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1039\/d4tb02364a","article-title":"Surface moieties drive the superior protection of curcumin-derived carbon quantum dots against retinal ischemia-reperfusion injury","volume":"13","author":"Sun","year":"2025","journal-title":"J. Mater Chem. B"},{"key":"B72","doi-asserted-by":"publisher","first-page":"Cd015532","DOI":"10.1002\/14651858.Cd015532","article-title":"Early versus late tracheostomy in critically ill COVID-19 patients","volume":"11","author":"Szafran","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.26355\/eurrev_202204_28594","article-title":"Molecular mechanisms revealed by network pharmacology of xuebijing on the treatment of acute respiratory distress syndrome caused by novel coronavirus infection","volume":"26","author":"Tao","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1080\/21655979.2021.1933301","article-title":"Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking","volume":"12","author":"Tianyu","year":"2021","journal-title":"Bioengineered"},{"key":"B75","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.2042-7158.2010.01191.x","article-title":"Effect and mechanism of senkyunolide I as an anti-migraine compound from Ligusticum chuanxiong","volume":"63","author":"Wang","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.taap.2013.07.021","article-title":"Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A","volume":"272","author":"Wang","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"113888","DOI":"10.1016\/j.jep.2021.113888","article-title":"Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: a retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China","volume":"277","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41401-021-00714-4","article-title":"Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B79","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3760\/cma.j.cn121430-20200406-00386","article-title":"Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019","volume":"32","author":"Wen","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1248\/bpb.35.515","article-title":"Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury","volume":"35","author":"Wu","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"B81","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/s1875-5364(20)60038-3","article-title":"Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019","volume":"18","author":"Xing","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"112752","DOI":"10.1016\/j.bios.2020.112752","article-title":"COVID-19 diagnosis -A review of current methods","volume":"172","author":"Y\u00fcce","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"B83","doi-asserted-by":"publisher","first-page":"107922","DOI":"10.1016\/j.intimp.2021.107922","article-title":"Senkyunolide I protect against lung injury via inhibiting formation of neutrophil extracellular trap in a murine model of cecal ligation and puncture","volume":"99","author":"Zha","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5582\/bst.2022.01534","article-title":"Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19","volume":"17","author":"Zhang","year":"2023","journal-title":"Biosci. Trends"},{"key":"B85","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","volume":"207","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1124\/dmd.117.079673","article-title":"Pharmacokinetics-Based identification of potential therapeutic phthalides from XueBiJing, a Chinese herbal injection used in sepsis management","volume":"46","author":"Zhang","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"B87","doi-asserted-by":"publisher","first-page":"172710","DOI":"10.1016\/j.ejphar.2019.172710","article-title":"Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu","volume":"864","author":"Zhang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"964","DOI":"10.13286\/j.1001-5213.2020.09.03","article-title":"Clinical efficacy observation of Xuebijing in the treatment of COVID-19","volume":"40","author":"Zhang","year":"2020","journal-title":"Zhong Guo Yi Yao Xue Za Zhi"},{"key":"B89","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.joim.2023.08.004","article-title":"Xuebijing injection, a Chinese patent medicine, against severe pneumonia: current research progress and future perspectives","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Integr. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12985-025-02666-1","article-title":"Antiviral treatment for viral pneumonia: current drugs and natural compounds","volume":"22","author":"Zhang","year":"2025","journal-title":"Virol. J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13040-020-00227-6","article-title":"Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology","volume":"13","author":"Zheng","year":"2020","journal-title":"BioData Min."},{"key":"B92","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00011-011-0359-9","article-title":"Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability","volume":"60","author":"Zhou","year":"2011","journal-title":"Inflamm. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1016\/s2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"B94","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpba.2017.01.024","article-title":"Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis","volume":"137","author":"Zuo","year":"","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B95","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpba.2017.09.010","article-title":"Simultaneous determination and pharmacokinetic study of twelve bioactive compounds in rat plasma after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS","volume":"146","author":"Zuo","year":"","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e4400","DOI":"10.1002\/bmc.4400","article-title":"Tissue distribution profiles of multiple major bioactive components in rats after intravenous administration of Xuebijing injection by UHPLC-Q-Orbitrap HRMS","volume":"33","author":"Zuo","year":"2019","journal-title":"Biomed. Chromatogr."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1667022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:39:28Z","timestamp":1771911568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1667022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":96,"alternative-id":["10.3389\/fphar.2025.1667022"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1667022","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1667022"}}